Back to Results
First PageMeta Content
Pharmaceutical sciences / Pharmacology / Maraviroc / Tropanes / Center for Drug Evaluation and Research / Pfizer / Antiretroviral drug / Dermatologic and Ophthalmic Drugs Advisory Committee / Food and Drug Administration / Chemistry / Clinical research


FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) ANTIVIRAL DRUGS ADVISORY COMMITTEE MEETING FDA ADVISORS AND CONSULTANTS STAFF CONFERENCE ROOM, RM[removed]FISHERS LANE; ROCKVILLE, MARYL
Add to Reading List

Document Date: 2007-04-20 08:28:06


Open Document

File Size: 98,97 KB

Share Result on Facebook

City

Boston / /

Company

Pfizer Inc. / /

Facility

Women’s Hospital / /

MedicalCondition

HIV / Infectious Diseases / /

Organization

ANTIVIRAL DRUGS ADVISORY COMMITTEE / Women’s Hospital / CENTER FOR DRUG EVALUATION AND RESEARCH / FOOD AND DRUG ADMINISTRATION / Division of Antiviral Products / office of Clinical Pharmacology / /

Person

Antiviral Drugs / Safety Scott Proestel / Introductory Remarks Katie Laessig / Lynn A. Paxton / Cicely Reese / Mike Westby / Armamentarium Dan Kuritzkes / Steve Felstead / Exposure-Response Modeling Pravin Jadhav / Michael Dunne / Efficacy Howard Mayer / Resistance Lisa Naeger / Mike Dunne / /

/

Position

Maraviroc Team Leader / Global Clinical Leader / Medical Officer / Pharmacometrician/Clinical Pharmacologist / PharmD Designated Federal Officer / Medical Team Leader / Therapeutic Area Head / Infectious Diseases / MPH Acting Chair / Virology Team Leader / /

SocialTag